Serum total Calcium to Magnesium ratio is higher in Sickle cell disease patients with proteinuria than without proteinuria by Emokpae, Abiodun Mathias & Adejumo, Babatunde Ishola Gabriel
Journal of Advances in Biological and Basic Research 01[03] 2015 
www.asdpub.com/index.php/jabbr                                                         ISSN-XXXX-XXXX (Online)                                                 
 
© ASD Publisher All rights reserved.                                                                                                                                                                                                         83 
Original Article 
 
Serum total Calcium to Magnesium ratio is higher in Sickle cell disease 
patients with proteinuria than without proteinuria 
 
Mathias Abiodun Emokpae and Babatunde Ishola Gabriel Adejumo 
 
Department of Medical Laboratory Science, School of Basic Medical Sciences, University of Benin, Benin City, 
Nigeria 
  
*Corresponding Author 
Dr. M. A Emokpae 
Department of Medical Laboratory Science, 
School of Basic Medical Sciences 
University of Benin, Benin City 
E-mail: mathias.emokpae@uniben.edu  
               biodunemokpae@yahoo.com  
 
Keywords: 
Serum calcium,  
Magnesium,  
Proteinuria,  
Sickle cell disease 
 
 
 
1. Introduction 
The intracellular balance in Calcium to Magnesium ratio is 
critical for normal physiological activities of the body because both 
have opposite functions. Calcium and magnesium are regulated 
together through dietary intake, negative feedback mechanism, 
intestinal absorption and renal re-absorption [1]. Calcium is an 
important essential element which must be balanced by adequate 
magnesium concentrations otherwise it may cause damage to cells of 
the body. Low concentrations of magnesium in sickled red blood cells 
have been associated with increased sickling, polymerization and 
dehydration [2-3].  The careful control of red blood cell volume in 
Sickle cell anaemia (SCA) is dependent to some extent on the 
changing equilibrium between calcium and magnesium, whereas 
calcium stimulates the movement of potassium and water from the 
cells through calcium-potassium channel (Gardos channel), 
magnesium inhibits potassium-chloride co-transport thereby 
promoting red blood cell hydration [4-5]. Findings in literature 
regarding the serum levels of calcium, magnesium and calcium to 
magnesium ratio in SCD patients have not been consistent. We earlier 
reported low magnesium levels in Sickle cell disease (SCD) patients 
compared to control subjects with normal haemoglobin [6]. Studies 
that have reported calcium to magnesium ratio in SCD patients 
evaluated ionized calcium and magnesium [7]. It was reported that 
differences in magnesium levels between SCA and HbAA were 
observed only by measuring ionized magnesium and not total serum 
magnesium levels. This was   due to low correlation between total 
and ionized magnesium. It was concluded that significant differences 
between SCD and HbAA would have been missed by measuring total 
serum magnesium [7]. Because of these observations, this study was 
designed to measure serum total calcium to magnesium ratio in SCD 
patients with proteinuria. It may help highlight the impact of 
proteinuria on the calcium to magnesium ratio and by extension their 
effect on red blood cell volume in this group of patients. A higher than 
normal serum ionized calcium to magnesium ratio has been 
associated with the activation of the Gardos channel leading to cell 
dehydration, sickled red blood sickling and vaso-occlusive disease 
[7]. 
Sickle cell nephropathy (SCN) is common and is a 
potentially life threatening condition in SCD patients. Functional 
changes occur in Kidneys of SCD patients and the prevalence 
increases with increasing ages of patients. Progressive renal failure at 
older ages is a major complication and cause of morbidity and 
mortility [8]. Factors that could predict renal failure in SCA patients 
include hypertension, proteinuria, anaemia, hyposthenuria and 
haematuria [9-10]. The environmental conditions (hypoxia, acidosis 
and hypertonicity) of renal medulla promote sickled cell 
polymerization, sickling and vaso-occlussive crisis [11]. Also the 
inability of the Kidney of SCD patients to concentrate urine maximally 
(hyposthenuria) may also contribute to renal abnormalities. This 
inability to maximally concentrate urine could predispose SCD 
patients to dehydration, vaso-occlusive crisis and urinary loss of 
these cations. The objective of this study was to evaluate the levels of 
total calcium to magnesium ratio in SCD patients with proteinuria. 
 
2. Materials and Methods 
2.1 Study participants 
This is a case-control study of 150 participants made up of 
100 SCD patients in steady clinical state and 50 apparently healthy 
subjects with Hb AA. The study protocol was reviewed and approved 
by the Ethics committee of the Edo State Ministry of Health, Benin 
City and all participants gave informed consent before the 
commencement of study. Demographic data, history of medication 
and blood transfusion were obtained using structured 
questionnaires. The participants were who met the selection criteria 
were consecutively enrolled. The SCD patients were on routine visit 
to the clinic and not on oral magnesium therapy for any reason. The 
study was conducted at the Department of Medical Laboratory 
Science, University of Benin, Benin City from January to December 
2014. The control subjects were staff and students of the University 
of Benin and patients were recruited into the study only once 
regardless of the number of visits to the clinic.  
2.2 Inclusion Criteria 
The individuals who made up the study group were 
confirmed sickle cell disease patients and were homozygote for sickle 
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cell haemoglobin (HbSS). They were on steady clinical state but 
presented to the clinic for their routine visits. They had no signs and 
symptoms of acute illness, such as vaso-occlusive crisis, acute chest 
syndrome or bacterial infection and were not transfused within the 
last 4 months before they were recruited into the study. 
2.3 Exclusion criteria 
Those with acute illness, on magnesium therapy for any 
reason or had received blood transfusion within the last 4 months 
were excluded. Subjects with other haemoglobinopathies were also 
excluded. 
2.4 Sample Preparation 
Blood samples (3mL) were collected by venepuncture 
from each subject and dispensed into plain containers. They were 
allowed to clot at room temperature. These were spun in a bucket 
centrifuge at a speed of 2500rpm for 10 minutes. The sera were kept 
frozen at a temperature of -20oC before the analyses were done. The 
measured parameters were assayed by colorimetric method. 
Magnesium and calcium were quantitated using reagents kits 
supplied by Teco diagnostics, Anaheim, USA and Randox 
Laboratories, UK respectively. Early morning urine specimens were 
also collected from the subjects. Urine protein was initially assayed 
using urinalysis dipsticks method while those that were positive for 
macroalbuminuria were re-evaluated using Sulphosalicylic acid (SSA) 
colorimetric technique. 
2.5 Data Analysis 
The mean±standard error of means of the cases and 
controls were compared using Students t-test. Pearson correlation 
coefficient was calculated in order to correlate the levels of measured 
variables with proteinuria. A p-value of 0.05 was considered 
statistically significant. 
 
3. Results 
The results from the study are as presented in tables 1,2 
and 3. One hundred adult SCD patients (male:female 55:45) were 
enrolled in the study. The age of the subjects ranged from 18 to 23 
years with a mean of 19.02±0.80. Out of the 100 SCD patients, 
27(27%) were positive for proteinuria while 73% were negative for 
proteinuria. Table 1 shows the levels of serum calcium, magnesium 
and calcium to magnesium ratio in SCD patients compared with 
control subjects. Statistically significant increases were observed for 
urine protein (p<0.02), serum calcium (p<0.002) and calcium to 
magnesium ratio (p<0.02) while significant decrease (p<0.001) in 
magnesium was observed in SCD patients compared with controls. 
Table 2 shows the levels of measured parameters in SCD patients 
with proteinuria and those without proteinuria. The mean age of 
those with proteinuria was significantly higher (p<0.02) than those 
without proteinuria. Statistically significant increases were observed 
for urine protein (p<0.001) and calcium to magnesium ratio 
(p<0.001), while significant decreases were observed for serum 
calcium (p<0.01) and magnesium (p<0.001) in patients with 
proteinuria compared to those without proteinuria. Table 3 shows 
that proteinuria correlated negatively with calcium (r-0.26; p<0.05), 
magnesium (r=-0.52; p<0.01) and positively with calcium to 
magnesium ratio (r=0.38; p<0.05) in SCD patients with proteinuria. 
 
Table 1: Levels of total serum calcium, magnesium and calcium to magnesium ratio in sickle cell disease patients compared with 
controls. 
Measured variables 
SCD patients 
(Hb SS)n=100 
Control subjects 
(HbAA) n=50 
p-value 
Age (Years) 19.02±0.80 22.31±1.01 0.001 
Urine Proteins(g/L) 0.050.02 00.0 0.02 
Serum Calcium(mmol/L) 2.42±0.03 2.32±0.04 0.002 
Serum Magnesium(mmol/L) 0.55±0.03 1.09±0.02 0.001 
Calcium/magnesium ratio 4.39±0.02 2.13±0.01 0.001 
Table 2: Levels of total serum calcium, magnesium and calcium to magnesium ratio in sickle cell disease patients with proteinuria 
compared to those without proteinuria 
Parameters 
SCD patients with proteinuria 
n=27 
SCD patients without proteinuria 
n=73 
p-value 
Age(years) 18.81±1.50 15.02±1.60 0.02 
Urine protein(g/L) 0.22±0.02 0.00 0.001 
Serum calcium(mmol/L) 2.25±0.03 2.34±0.04 0.01 
Serum magnesium(mmol/L) 0.49±0.05 0.92±0.03 0.001 
Calcium/magnesium ratio 4.59±0.04 2.23±0.02 0.001 
 
Table 3: Correlation of proteinuria with measured variables in SCD patients 
Parameters R-value P-value 
Macroalbuminuria and serum calcium -0.26 p>0.05 
Macroalbuminuria and serum magnesium -0.52 0.01 
Macroalbuminuria and calcium/magnesium ratio 0.38 0.05 
 
4. Discussion  
The aim of this study was to evaluate the impact of 
proteinuria on the levels of calcium, magnesium and calcium to 
magnesium ratio. The data presented showed that urine protein, 
serum calcium and calcium to magnesium ratio were significantly 
higher while serum magnesium was significantly lower in SCD 
patients compared with control subjects. The SCD patients with 
proteinuria had significantly higher (p<0.001) levels of urine protein 
and calcium to magnesium ratio, decrease levels of serum calcium 
(p<0.01) and magnesium (p<0.001) compared to those without 
proteinuria. Increased serum calcium to magnesium ratio is an 
indication of intracellular imbalance in calcium and magnesium 
levels. Increased serum calcium and low magnesium levels promote 
or activate Gardos channel and de-activation of potassium-chloride 
co-transport mechanism, thereby leading to cellular dehydration [7]. 
The decrease magnesium levels as observed in this study 
are consistent with previous studies [2,6,12]. Our observation did not 
agree with others who reported decreased levels of ionized 
magnesium and not total magnesium. They reported significantly 
decrease in total magnesium levels in SCA patients compared with 
Caucasians and not between SCA and AA groups of African 
Americans. Differences in magnesium levels between SCA and AA 
control group were only observed by measuring serum ionized 
magnesium and not total magnesium levels [7]. Measurements of 
calcium to magnesium ratio in several disease conditions have 
yielded conflicting findings, examples include Diabetes mellitus and 
cardiovascular diseases [13-16]. Low plasma magnesium level but 
increased red blood cells magnesium was reported in children with 
SCD [17]. On the contrary, a higher serum magnesium level in SCD 
patients than controls was observed in another study which was 
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attributed to chronic haemolytic states in the SCD patients [18]. No 
significant difference between serum magnesium levels in Nigerian 
SCD patients compared with HbAA controls was also reported [19].  
The calcium to magnesium ratio observed in this study 
between SCD patients and controls (4.39±0.02 vs 2.13±0.01) was 
higher than 2.42±0.213 vs 2.09±0.16 and 1.955±0.10 reported for 
SCA patients, African American controls and Caucasians respectively 
using ionized calcium and magnesium [7]. The high calcium to 
magnesium ratio was thought to result in activation of the Gardos 
channel, sickled red blood cell sickling, dehydration, vaso-occlusive 
crisis. These complications often lead to proteinuria which is a 
manifestation of glomerular injury in SCD patients. Some of the 
factors that may predict renal insufficiency in SCD patients such as 
hypertension, anaemia and haematuria may be exacerbated by 
higher calcium to magnesium ratio. A sustained imbalance in the 
calcium to magnesium ratio over a period of time may results in 
excited firing state of biochemistry of the cells [20]. In SCD patients 
(who are constantly under stress condition), muscle, nerves, 
hormone secreting cells and inflammatory response may go into an 
overreaction mode [20]. In addition, calcium levels may get 
excessively high due to low magnesium which will further activate 
potassium and water loss (cellular dehydration). The significant 
decreases in serum calcium and magnesium levels and higher 
calcium to magnesium ratio observed in SCD patients with 
proteinuria may be as a result of urinary loss of calcium and 
magnesium. 
In this study, total instead of ionized calcium and 
magnesium levels were determined because the former are readily 
available in our setting. Because these essential elements regulate 
electrolytes and water movement between intra and extracellular 
spaces their measurements could be used in the management of 
these patients [21-23]. The ratio is of importance in assessing the 
potential dehydration status of SCA patients with proteinuria. 
Increased potassium loss and cellular dehydration seen in these 
patients may be promoted by high calcium and low magnesium 
levels.  
 
5. Conclusion  
Total serum calcium to magnesium ratio is higher in SCD 
patients with proteinuria than those with proteinuria. The ratio could 
be routinely calculated to assess the imbalance of these essential 
elements. 
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